BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,000 | -60.3% | 11,099 | -52.1% | 0.03% | -55.9% |
| Q2 2023 | $1,063,000 | +231490.4% | 23,164 | +104.7% | 0.06% | +68.6% |
| Q1 2023 | $459 | -68.5% | 11,315 | -60.1% | 0.04% | -62.8% |
| Q4 2022 | $1,455 | -99.6% | 28,387 | +525.0% | 0.09% | +571.4% |
| Q1 2021 | $398,000 | +24.0% | 4,542 | +13.7% | 0.01% | 0.0% |
| Q4 2020 | $321,000 | -0.9% | 3,995 | -0.8% | 0.01% | -12.5% |
| Q3 2020 | $324,000 | -6.9% | 4,028 | -0.3% | 0.02% | -15.8% |
| Q2 2020 | $348,000 | +5.8% | 4,040 | -0.3% | 0.02% | -20.8% |
| Q1 2020 | $329,000 | -27.4% | 4,054 | -25.1% | 0.02% | -31.4% |
| Q4 2019 | $453,000 | +4.1% | 5,412 | +8.8% | 0.04% | -2.8% |
| Q3 2019 | $435,000 | -3.5% | 4,976 | -10.2% | 0.04% | -28.0% |
| Q1 2019 | $451,000 | +17.4% | 5,542 | -5.0% | 0.05% | -7.4% |
| Q4 2018 | $384,000 | -9.9% | 5,831 | +5.6% | 0.05% | -12.9% |
| Q3 2018 | $426,000 | +9.2% | 5,522 | 0.0% | 0.06% | -25.3% |
| Q2 2018 | $390,000 | -11.8% | 5,522 | -11.9% | 0.08% | -24.5% |
| Q1 2018 | $442,000 | -10.7% | 6,269 | -12.3% | 0.11% | -9.1% |
| Q4 2017 | $495,000 | +8.6% | 7,148 | +0.7% | 0.12% | +1.7% |
| Q3 2017 | $456,000 | +6.5% | 7,098 | -1.1% | 0.12% | -1.7% |
| Q2 2017 | $428,000 | +3.6% | 7,174 | +1.3% | 0.12% | -0.8% |
| Q1 2017 | $413,000 | +27.1% | 7,081 | +6.8% | 0.12% | +11.9% |
| Q4 2016 | $325,000 | – | 6,630 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |